0000899243-16-014988.txt : 20160302
0000899243-16-014988.hdr.sgml : 20160302
20160302163327
ACCESSION NUMBER: 0000899243-16-014988
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160301
FILED AS OF DATE: 20160302
DATE AS OF CHANGE: 20160302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCA biopharma, Inc.
CENTRAL INDEX KEY: 0000907654
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 363855489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
BUSINESS PHONE: 720-940-2200
MAIL ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
FORMER COMPANY:
FORMER CONFORMED NAME: NUVELO INC
DATE OF NAME CHANGE: 20030203
FORMER COMPANY:
FORMER CONFORMED NAME: HYSEQ INC
DATE OF NAME CHANGE: 19970610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keuer Thomas A
CENTRAL INDEX KEY: 0001290482
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22873
FILM NUMBER: 161477534
MAIL ADDRESS:
STREET 1: C/O ARCA BIOPHARMA, INC.
STREET 2: 11080 CIRCLEPOINT RD, STE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-03-01
0
0000907654
ARCA biopharma, Inc.
ABIO
0001290482
Keuer Thomas A
ARCA BIOPHARMA, INC.
11080 CIRCLEPOINT ROAD, SUITE 140
WESTMINSTER
CO
80020
0
1
0
0
Chief Operating Officer
Common Stock
2016-03-01
4
S
0
457
3.53
D
16481
D
Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person for satisfaction of their tax withholding obligation with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Equity Incentive Plan (the "Plan").
Includes (i) remaining 2,143 previously reported shares issued as RSUs under the Plan that vests on 9/17/16, (ii) remaining 1,429 previously reported shares issued as RSUs under the Plan that vests on 10/15/16, (iii) remaining 2,443 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning on 2/27/17, and (iv) 3,621 previously reported shares issued as RSUs under the Plan that vest in three equal annual installments beginning April 2, 2016, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 6,845 previously reported shares of common stock owned.
/s/ Brian L. Selby, Attorney-in-Fact
2016-03-02